Caristo provides AI-powered cardiovascular diagnostic solutions for early detection and prevention of heart attacks.

Caristo Diagnostics

Caristo

Caristo Diagnostics has been formed to bring revolutionary cardiovascular diagnostic tools to patients worldwide. Our proprietary technology transforms the accuracy of routine cardiac CT scans by extracting new information that is otherwise invisible, greatly enhancing the power to predict cardiovascular risk and refine treatment decisions.

Our Website: https://www.caristo.com

Follow us on Twitter: https://twitter.com/CaristoHeart

Longwall Venture Partners

Oxford Science Enterprises

Oxford Investment Consultants LLP

We’re gearing up for #ESC2024 in London! 
📅 Save the Date: Join us at our satellite symposium to explore groundbreaking insights into coronary artery disease prevention through the lens of coronary inflammation. Learn more - https://lnkd.in/dkb8u5hu 

💬 Meet Us at ESC: Book a meeting at booth C600 to meet the Caristo Medical and Business team and discover our innovative CaRi-Heart Technology. 
Schedule a booth appointment - https://lnkd.in/e9FD6ZQm 

European Society of Cardiology, Prof Peter Libby, Prof John Deanfield CBE, Prof Ron Blankstein, Prof Charalambos Antoniades, Harvard Medical School, Brigham and Women's Hospital, University of Oxford

#Prevention #Cardiovasculardisease #heartattack #FAIScore #coronaryinflammation

We had an incredible symposium chaired by Prof. Peter Libby, Brigham and Women's Hospital and Harvard Medical School, and Prof. John Deanfield CBE, University College London, at #ESC2024. Highlights included excellent presentations from Prof. Ron Blankstein (Brigham and Women's Hospital and Harvard Medical School) and Prof. Charalambos Antoniades (University of Oxford) on the evolution of CAD diagnosis, shifting from stenosis to coronary inflammation, as measured by the FAI-Score. Thank you all for joining us. 

To learn more about the FAI-Score, visit us at the Caristo booth #C600! 

Discover more - https://lnkd.in/dZQb6927 
European Society of Cardiology #FAIScore #CoronaryInflammation #CardiovascularDisease #Prevention #HeartDisease #HeartAttackRisk

Caristo at #ESC2024 in London!  
💡 Attend our symposium to explore groundbreaking insights into coronary artery disease prevention through the lens of coronary inflammation.  
👉 Meet us at booth C600 to discover our innovative CaRi-Heart Technology. https://bit.ly/3VL3acQ 

#CoronaryInflammation #FAIScore #MedicalInnovation #Healthcare #Congress #Imaging

We were delighted to welcome Dr. Andrew Mitchell, Consultant Cardiologist at Jersey General Hospital and Honorary Consultant at Oxford University Hospitals NHS Foundation Trust, to our Oxford HQ this week. Our product, clinical, and business teams had engaging and productive discussions with him. We look forward to expanding access to CaRi-Heart, ensuring even more patients in the Channel Islands of Jersey benefit from our innovative solution. 

💡 Learn more about CaRi-Heart Technology on our website - https://lnkd.in/euTKa2im

#CoronaryInflammation #FAIScore #MedicalInnovation #Healthcare

We're #hiring a new Image Analyst in Oxfordshire, England. Apply today or share this post with your network.

Excellent news Dr Murray, having researched this technology, this is a game changer , moving to an absolute risk, as opposed to using existing models that can under estimate risk is essential given cardiovascular disease is the leading cause of mortality, looomg forward to our collaboration

CARI

COM:CARISTO

Caristo

locale

market

industry

website

linkedin

founding date

investor of

Metrics